be_ixf;ym_202410 d_05; ct_50
AMEX:PICK charts & data provided by TradingView

Latest Insights on PICK

Buying, selling, laughing? Anything goes in this market. Hear how Great Stuff readers stay sane amid the insanity. Have Feedback, Will Travel: Economy, Cruises and Puts
by Joseph Hargett October 29, 2020 Great Stuff
The “All of the Above” Economy ‘Sup, Great Ones? Welcome to Reader Feedback day! Today, as always, is about you. Your stock market questions. Your investment hopes. Your Wall Street rants. Your deepest options desires. Um … desires, Mr. Great Stuff? Don’t worry, I won’t pull any of that Tom Ellis Lucifer mojo on you. […]
How to Find Tech’s Next 10X Winners
by Brian Christopher October 29, 2020 Investment Opportunities, Technology, Winning Investor Daily
Many of you have heard about the new technologies already among us. But have you ever wondered how to play them?
You know what they say about baseball card collecting in the ‘80s and the stock market. Well, maybe you don’t, but it ain’t pretty… Winter Is Coming; Forests of Azure, Cloudless Solar Skies
by Joseph Hargett October 28, 2020 Great Stuff
Future in the Cards Sooo … how about those Dodgers? I don’t follow baseball — I got burned on baseball cards back in the late ‘80s and early ‘90s, and it’s been downhill ever since. Anyone else have a massive box of three-decades-old baseball cards that are worth absolutely nothing right now? Oddly enough, there’s […]
It’s the changing of the guard. A capitalist election of the highest order. Intel is no longer inside. Behold AMD’s ascent! AMD Ascends; S&P Double-Plus Bad; Leaving Las Vegas
by Joseph Hargett October 27, 2020 Great Stuff
House of the Ryzen Sun Great Ones, we’re watching an era end in the semiconductor market. A changing of the guard. A capitalist election of the highest order. No longer does “Intel Inside” rule the roost. Behold AMD’s ascent. Okay, somebody’s got delusions of grandeur. Too much Death Wish coffee this morning? What gives, Mr. […]
Invest in Biotech With 1 Buy
by Chad Shoop October 27, 2020 2020 Financial Crisis, American Investor Today
(9-minute video) In the war against COVID-19, American biotech companies are paving the path. The latest success is Gilead’s remdesivir winning FDA approval. Will this be the start of a new uptrend for the stock?

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

Share This